Parkinson's & Movement disorders

Shining a light on protein aggregation in Parkinson's disease

A novel system to control protein aggregation in a model of Parkinson's disease may answer longstanding questions about how the disease begins and spreads, according to a new study published March 9 in the open-access journal ...

Parkinson's & Movement disorders

Exercise hormone halts Parkinson's disease symptoms in mouse study

Researchers from Johns Hopkins Medicine and the Dana Farber Cancer Institute in Boston have shown that a hormone secreted into the blood during endurance, or aerobic, exercise reduces levels of a protein linked to Parkinson's ...

Neuroscience

A new mutation behind synucleinopathies

Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called ...

Parkinson's & Movement disorders

Researchers stimulate improvements in Parkinson's treatment

New research led by QIMR Berghofer Medical Research Institute has identified ways to make the most widely-used advanced treatment for Parkinson's disease—deep brain stimulation therapy—more effective and safer.

page 12 from 40